| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.0086 | 1 |